329 related articles for article (PubMed ID: 30882490)
1. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
Coffey S; Bacchetti P; Sachdev D; Bacon O; Jones D; Ospina-Norvell C; Torres S; Lynch E; Camp C; Mercer-Slomoff R; Lee S; Christopoulos K; Pilcher C; Hsu L; Jin C; Scheer S; Havlir D; Gandhi M
AIDS; 2019 Apr; 33(5):825-832. PubMed ID: 30882490
[TBL] [Abstract][Full Text] [Related]
2. Decreased Time From Human Immunodeficiency Virus Diagnosis to Care, Antiretroviral Therapy Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco.
Bacon O; Chin J; Cohen SE; Hessol NA; Sachdev D; Coffey S; Scheer S; Buchbinder S; Havlir DV; Hsu L
Clin Infect Dis; 2021 Jul; 73(1):e122-e128. PubMed ID: 32449916
[TBL] [Abstract][Full Text] [Related]
3. Rapid Antiretroviral Therapy (ART) Initiation at a Community-Based Clinic in Jackson, MS.
Gomillia CES; Backus KV; Brock JB; Melvin SC; Parham JJ; Mena LA
AIDS Res Ther; 2020 Oct; 17(1):60. PubMed ID: 33032617
[TBL] [Abstract][Full Text] [Related]
4. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic.
Christopoulos KA; Grochowski J; Mayorga-Munoz F; Hickey MD; Imbert E; Szumowski JD; Dilworth S; Oskarsson J; Shiels M; Havlir D; Gandhi M
Clin Infect Dis; 2023 Feb; 76(3):e645-e651. PubMed ID: 35913500
[TBL] [Abstract][Full Text] [Related]
5. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria.
Meloni ST; Chang CA; Eisen G; Jolayemi T; Banigbe B; Okonkwo PI; Kanki PJ
PLoS One; 2016; 11(10):e0164030. PubMed ID: 27764094
[TBL] [Abstract][Full Text] [Related]
8. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes.
Moorhouse M; Maartens G; Venter WDF; Moosa MY; Steegen K; Jamaloodien K; Fox MP; Conradie F
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):73-78. PubMed ID: 30334876
[TBL] [Abstract][Full Text] [Related]
9. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
[TBL] [Abstract][Full Text] [Related]
11. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
[TBL] [Abstract][Full Text] [Related]
12. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.
Gandhi M; Hickey M; Imbert E; Grochowski J; Mayorga-Munoz F; Szumowski JD; Oskarsson J; Shiels M; Sauceda J; Salazar J; Dilworth S; Nguyen JQ; Glidden DV; Havlir DV; Christopoulos KA
Ann Intern Med; 2023 Jul; 176(7):969-974. PubMed ID: 37399555
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression.
Gianotti N; Marchetti G; Antinori A; Saracino A; Gori A; Rizzardini G; Lichtner M; Bandera A; Mussini C; Girardi E; dʼArminio Monforte A; Cozzi-Lepri A
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):417-422. PubMed ID: 28816721
[TBL] [Abstract][Full Text] [Related]
14. Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.
O'Connor JL; Smith CJ; Lampe FC; Hill T; Gompels M; Hay P; Chadwick D; Fisher M; Ainsworth J; Gilson R; Mackie N; Anderson J; Orkin C; Nelson M; Kegg S; Leen C; Palfreeman A; Post F; Johnson M; Sabin CA; Phillips AN;
AIDS; 2014 Mar; 28(6):919-24. PubMed ID: 24335482
[TBL] [Abstract][Full Text] [Related]
15. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
[TBL] [Abstract][Full Text] [Related]
16. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.
Penot P; Héma A; Bado G; Kaboré F; Soré I; Sombié D; Traoré JR; Guiard-Schmid JB; Fontanet A; Slama L; Bruno Sawadogo A; Laurent C
J Int AIDS Soc; 2014; 17(1):18646. PubMed ID: 24433983
[TBL] [Abstract][Full Text] [Related]
17. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
[TBL] [Abstract][Full Text] [Related]
18. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
Bahemana E; Esber A; Dear N; Ganesan K; Parikh A; Reed D; Maganga L; Khamadi S; Mizinduko M; Lwilla A; Mkondoo D; Mwaisanga G; Somi N; Owouth J; Maswai J; Kiweewa F; Iroezindu M; Ake JA; Crowell TA; Valcour VG; Polyak CS;
AIDS Res Ther; 2020 Nov; 17(1):66. PubMed ID: 33183355
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
[TBL] [Abstract][Full Text] [Related]
20. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
